Botanical Drug Development Roundtable
With apologies for the short notice, we are postponing this week's Roundtable on Improving Botanical Drug Development. Unfortunately, FDA was unable to prioritize the funding for this issue. We will reschedule as soon as possible.
The Reagan-Udall Foundation for the FDA, in collaboration with the FDA's Center for Drug Evaluation and Research, is convening an invitation only roundtable to:
- Identify current challenges in botanical drug development
- Explore opportunities to accelerate the development of botanical drug products in the United States